Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bazedoxifene launched in Japan and Spain for postmenopausal osteoporosis

Oct. 15, 2010

Continuous exenatide delivery with ITCA-650 shows promise in phase II diabetes trial

Oct. 15, 2010

Prosidion describes new GPR119 receptor agonists

Oct. 15, 2010

Boehringer Ingelheim discontinues flibanserin development

Oct. 14, 2010

Merck Frosst discovers novel acyl-CoA desaturase inhibitors

Oct. 14, 2010

Piramal Life Sciences describes preclinical pharmacology of new insulin sensitizer P-1738

Oct. 14, 2010

FDA approves delayed-release risedronate sodium for postmenopausal osteoporosis

Oct. 13, 2010

Prosidion discloses new GPR119 receptor agonists

Oct. 13, 2010

Bayer's contraceptive Qlaira approved in E.U. to treat heavy menstrual bleeding

Oct. 11, 2010

Abbott to withdraw obesity drug Meridia from U.S. market

Oct. 11, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...